Short Duration of Elevated vIRF-1 Expression during Lytic Replication of Human Herpesvirus 8 Limits Its Ability To Block Antiviral Responses Induced by Alpha Interferon in BCBL-1 Cells
Open Access
- 15 June 2004
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (12) , 6621-6635
- https://doi.org/10.1128/jvi.78.12.6621-6635.2004
Abstract
Human herpesvirus 8 (HHV-8) encodes multiple proteins that disrupt the host antiviral response, including viral interferon (IFN) regulatory factor 1 (vIRF-1). The product of the vIRF-1 gene blocks responses to IFN when overexpressed by transfection, but the functional consequence of vIRF-1 that is expressed during infection with HHV-8 is not known. These studies demonstrate that BCBL-1 cells that were latently infected with HHV-8 expressed low levels of vIRF-1 that were associated with PML bodies, whereas much higher levels of vIRF-1 were transiently expressed during the lytic phase of HHV-8 replication. The low levels of vIRF-1 that were associated with PML bodies were insufficient to block alpha IFN (IFN-α)-induced alterations in gene expression, whereas cells that expressed high levels of vIRF-1 were resistant to some changes induced by IFN-α, including the expression of the double-stranded-RNA-activated protein kinase. High levels of vIRF-1 were expressed for only a short period during the lytic cascade, so many cells with HHV-8 in the lytic phase responded to IFN-α with increased expression of antiviral genes and enhanced apoptosis. Furthermore, the production of infectious virus was severely compromised when IFN-α was present early during the lytic cascade. These studies indicate that the transient expression of high levels of vIRF-1 is inadequate to subvert many of the antiviral effects of IFN-α so that IFN-α can effectively induce apoptosis and block production of infectious virus when present early in the lytic cascade of HHV-8.Keywords
This publication has 71 references indexed in Scilit:
- A Domain in the C-Terminal Region of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Affects Transcriptional Activation and Binding to Nuclear HeterochromatinJournal of Virology, 2003
- The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activationJournal of General Virology, 2003
- The spindle checkpoint: structural insights into dynamic signallingNature Reviews Molecular Cell Biology, 2002
- DNA viruses and viral proteins that interact with PML nuclear bodiesOncogene, 2001
- Host defense, viruses and apoptosisCell Death & Differentiation, 2001
- Characterization of the promoter region of the viral interferon regulatory factor encoded by Kaposi's sarcoma-associated herpesvirusOncogene, 2001
- Viral Interferon Regulatory Factor 1 of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Binds to, and Inhibits Transactivation of, CREB-Binding ProteinBiochemical and Biophysical Research Communications, 2000
- When Two Strands Are Better Than One: The Mediators and Modulators of the Cellular Responses to Double-Stranded RNAVirology, 1996
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Respective roles of centrosomes and chromatin in the conversion of microtubule arrays from interphase to metaphase.The Journal of cell biology, 1984